Last reviewed · How we verify
picrotin
picrotin is a drug. It is currently in unknown development.
At a glance
| Generic name | picrotin |
|---|---|
| Target | Glycine receptor subunit alpha-2, Glycine receptor subunit alpha-3, Glycine receptor subunit alpha-1 |
| Therapeutic area | Metabolic |
| Phase | unknown |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- picrotin CI brief — competitive landscape report
- picrotin updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about picrotin
What is picrotin?
picrotin is a pharmaceutical drug.
What development phase is picrotin in?
picrotin is in unknown.
What does picrotin target?
picrotin targets Glycine receptor subunit alpha-2, Glycine receptor subunit alpha-3, Glycine receptor subunit alpha-1.
Related
- Target: All drugs targeting Glycine receptor subunit alpha-2, Glycine receptor subunit alpha-3, Glycine receptor subunit alpha-1
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Metabolic
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing